VDMAX
Price
$10.23
Change
-$0.01 (-0.10%)
Updated
Jul 3 closing price
Net Assets
3.95M
VEMIX
Price
$31.21
Change
-$0.34 (-1.08%)
Updated
Jul 7 closing price
Net Assets
124.04B
Interact to see
Advertisement

VDMAX vs VEMIX

Header iconVDMAX vs VEMIX Comparison
Open Charts VDMAX vs VEMIXBanner chart's image
Virtus KAR Developing Markets A
Price$10.23
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets3.95M
Vanguard Emerging Mkts Stock Idx Instl
Price$31.21
Change-$0.34 (-1.08%)
VolumeN/A
Net Assets124.04B
VDMAX vs VEMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VDMAX vs. VEMIX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VDMAX is a Buy and VEMIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 124B vs. VDMAX (3.95M). VEMIX pays higher dividends than VDMAX: VEMIX (2.79) vs VDMAX (1.52). VDMAX was incepted earlier than VEMIX: VDMAX (4 years) vs VEMIX (25 years). VDMAX (4.77) is less costly to investors than VEMIX (0.09). VDMAX is a more actively managed with annual turnover of: 25.00 vs. VEMIX (8.00). VDMAX has a lower initial minimum investment than VEMIX: VDMAX (2500) vs VEMIX (5000000). VDMAX annual gain was more profitable for investors over the last year : 23.25 vs. VEMIX (12.80).
VDMAXVEMIXVDMAX / VEMIX
Total Expense Ratio1.330.091,478%
Annual Report Gross Expense Ratio4.770.095,300%
Fund Existence4 years25 years-
Gain YTD20.35311.902171%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.95M124B0%
Annual Yield % from dividends1.522.7955%
Returns for 1 year23.2512.80182%
Returns for 3 years45.8727.89164%
Returns for 5 yearsN/A25.95-
Returns for 10 yearsN/A47.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOD3.950.19
+5.05%
Kodiak Sciences
NRIX12.730.29
+2.33%
Nurix Therapeutics
OKE82.141.15
+1.42%
Oneok
ITRI135.691.61
+1.20%
Itron
IMDX2.85-0.19
-6.25%
Insight Molecular Diagnostics Inc